Generating Robust Clinical Trial Data with the nCounter Analysis System
Webinar
View On Demand
Our first session is dedicated to direct detection gene expression analysis with the nCounter platform. Join NanoString and subject matter experts from academia and CROs as we discuss how nCounter panel content and gene expression profiling (GEP) signatures can be used to accelerate drug discovery and development:
- nCounter Analysis System technology overview
- Scientific presentation
- Spotlight CRO presentations highlighting validation studies, performance data and capability offerings
Agenda:
| Title | Speaker |
| nCounter Introduction | Maxine McClain, PhD |
| Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses | William Chen, M.D. |
| nCounter IO 360 Validation & Services Offered | James Cox, MS |
| From Pre-Clinical to Clinical: Life of an nCounter study at Propath UK | Joana Campos, PhD |
Speakers
Maxine McClain, PhD
Field Applications Scientist Senior Manager, NanoString Technologies
James Cox, MS
Scientist, Research & Development, Eurofins
William Chen, M.D.
Clinical Instructor, Department of Radiation Oncology, University of California, San Francisco
